LONDON, May 14 (Reuters) – Companies that develop new
antibiotics should be awarded prize money of up to $3.5 billion
for each new drug, instead of selling the medication at a
profit, a review backed by Britain’s government said on
The review, lead by former Goldman Sachs chief economist Jim
O’Neill, said the lump sum payments could add up to $16-$37
billion over 10 years, but should only be made when companies
have fully developed a successful bug-killing drug.
LONDON (Reuters) – An antibiotic-resistant “superbug” strain of typhoid fever has spread globally, driven by a single family of the bacteria, called H58, according to the findings of a large international study.
The research, involving some 74 scientists in almost two dozen countries, is one of the most comprehensive sets of genetic data on a human infectious agent and paints a worrying scene of an “ever-increasing public health threat”, they said.
LONDON, April 30 (Reuters) – The world is closer than ever
to being able to wipe out polio, international experts said on
Thursday, with zero cases of the crippling disease recorded
across all of Africa this year and fewer than 25 globally.
Polio eradication specialists are wary of claiming premature
success and warn complacency could prove the project’s downfall,
but with only two countries, Pakistan and Afghanistan, reporting
polio cases in 2015, they see an end in sight.
LONDON (Reuters) – Only 34 countries have national plans to fight the global threat of antibiotic resistance, meaning few are prepared to tackle “superbug” infections which put even basic healthcare at risk, the WHO said on Wednesday.
In a survey of government plans to tackle the issue, the World Health Organization said only a quarter of the 133 countries that responded were addressing the problem.
LONDON, April 28 (Reuters) – Black Americans who switched to
a high-fibre African diet for just two weeks saw a dramatic drop
in risk factors for colon cancer, a study published on Tuesday
A group of Africans who went the other way and started
eating American food rich in animal proteins and fats saw their
risks rise over the same short period, according to the paper in
the journal Nature Communications.
LONDON, April 24 (Reuters) – The world’s first malaria
vaccine, made by GlaxoSmithKline, could be approved by
international regulators for use in Africa from October after
final trial data showed it offered partial protection for up to
The shot, called RTS,S and designed for children in Africa,
would be the first licensed human vaccine against a parasitic
disease and could help prevent millions of cases of malaria,
which currently kills more than 600,000 people a year.
LONDON, April 21 (Reuters) – Genetic sequence data on two of the deadliest yet most poorly understood viruses are to be made available to researchers worldwide in real time as scientists seek to speed up understanding of Ebola and MERS infections.
The project, led by British scientists with West African and Saudi Arabian collaboration, hopes to encourage laboratories around the world to use the live data — updated as new cases emerge — to find new ways to diagnose and treat the killer diseases, and ideally, ultimately, prevent them.
LONDON (Reuters) – The brains of babies “light up” in a similar way to adults when exposed to the same painful stimulus, suggesting they feel pain much like adults do, researchers said on Tuesday.
In the first of its kind study using magnetic resonance imaging (MRI), scientists from Britain’s Oxford University found that 18 of the 20 brain regions active in adults experiencing pain were also active in babies.
LONDON (Reuters) – Two new studies looking at whether electronic cigarettes help smokers to quit their deadly habit have found that while some of them can, it depends on the type and how often it is used.
The research — welcomed by experts in a field marked by a dearth of good scientific evidence and intense lobbying — suggests daily use of so-called “tank” e-cigarettes, designed to be refilled with nicotine-containing liquids, is most likely to help smokers quit.
LONDON, April 21 (Reuters) – Mindfulness-based cognitive
therapy (MBCT) may be just as effective as anti-depressants in
helping prevent people with chronic depression from relapsing,
scientists said on Tuesday.
Depression is one of the most common forms of mental
illness, affecting more than 350 million people worldwide. It is
ranked by the World Health Organization as the leading cause of